Clinical Trials in Atlanta

Showing 4661-4680 of 19,805 trials

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

NCT04454463

The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.

Liver Diseases

Johns Hopkins Bloomberg School of Public Health1,649 participantsStarted Nov 2020

La Jolla, California, United States • Los Angeles, California, United States • San Diego, California, United States +13 more locations

Active Not RecruitingNA< 1 mile

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

NCT02489539

The purpose of the study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal aorta. Performance of the GORE® EXCLUDER® Conformable AAA Endoprosthesis will be judged by separate performance goals.

Aortic Aneurysm, Abdominal

W.L.Gore & Associates175 participantsStarted Dec 2017

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +48 more locations

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

Find Trials by Condition in Atlanta

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Mental Stress and Myocardial Ischemia After MI: Sex Differences, Mechanisms and Prognosis

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Expanded Access of Sotorasib

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma